Delivery Order SPE2DX22D0019-SPE2D825FHM04
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $26,825.20 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999.99 billion ceiling value and extends through December 2026. The delivery order was issued...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $56,812 to AmerisourceBergen Drug Corp on July 25, 2025, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed-price arrangement and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, serves as...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency's Medical Supply Chain awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $27,999.27 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor for federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $42,979.58 to AmerisourceBergen Drug Corp on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contracting vehicle serves as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, with a ceiling value of $1,192.02 and an ultimate completion date of July 30, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is firm fixed price, non-competitive set-aside, and will...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D825FHM04Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,440.70 to AmerisourceBergen Drug Corp on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price contract, issued under contract number 4569014853, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The order will be performed at the company's corporate office in Conshohocken, Pennsylvania. As a non-set-aside competitive award, this delivery order reflects AmerisourceBergen's established capability as a critical federal pharmaceutical vendor supplying medications, vaccines, and medical devices to military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999.99 billion IDC with DLA Troop Support Medical extending through December 2026, which serves as the umbrella contract for this delivery order. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, and medical supplies. This delivery order exemplifies the company's role in supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible, competitively awarded contract vehicles designed to meet global military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/7/25 |